Table III.
Percentage of viable, early and late apoptotic helper and cytotoxic T lymphocytes from patients undergoing anaesthesia with ISF
| T lymphocytes | CD4+ |
CD8+ |
||||
| T1 | T2 | T3 | T1 | T2 | T3 | |
| Viable | 91.9 (89.3–93.7) | 91.7 (88.1–93.2) | 93.1 (91.2–94.4) | 91.9 (87.3–95.6) | 92.1 (88.5–94.2) | 93.4 (91.4–95.3) |
| Early apoptosis | 7.0 (4.8–9.8) | 7.4 (5.5–11.0) | 5.5 (4.2–7.9) | 7.9 (3.9–12.1) | 7.0 (5.4–9.9) | 5.3 (4.2–8.1) |
| Late apoptosis | 1.0 (0.7–1.2) | 0.9 (0.6–1.3) | 1.0 (0.6–1.5) | 0.2 (0.1–0.3) | 0.2 (0.2–0.4) | 0.2 (0.1–0.2) |
T1: before anaesthesia; T2: 2 h after the beginning of anaesthesia and T3: on the first post-operative day. Data, obtained from 20 subjects, are expressed as median and quartiles; P > 0.05.